In/IN
Silico/NN
Screening/JJ
for/IN
Angiogenesis-Related/JJ
Genes/NNS
in/IN
Rat/NN
Astrocytes/NNS
./.
====================
Astrocytes/NNS
play/VBP
supportive/JJ
roles/NNS
for/IN
neurons/NNS
in/IN
the/DT
brain/NN
./.
====================
Recently/RB
,/,
they/PRP
have/VBP
been/VBN
accepted/VBN
to/TO
have/VB
various/JJ
functions/NNS
in/IN
the/DT
vascular/JJ
system/NN
as/IN
well/RB
as/IN
in/IN
the/DT
nervous/JJ
system/NN
./.
====================
We/PRP
investigated/VBD
the/DT
differential/JJ
gene/NN
expression/NN
in/IN
rat/NN
astrocytes/NNS
according/VBG
to/TO
the/DT
oxygen/NN
tension/NN
,/,
which/WDT
is/VBZ
a/DT
crucial/JJ
factor/NN
for/IN
angiogenesis/NN
./.
====================
A/DT
cDNA/NN
microarray/NN
was/VBD
performed/VBN
to/TO
find/VB
the/DT
genes/NNS
whose/WP$
expression/NN
was/VBD
sensitive/JJ
to/TO
oxygen/NN
tension/NN
./.
====================
We/PRP
found/VBD
26/CD
genes/NNS
in/IN
the/DT
astrocyte/NN
were/VBD
found/VBN
and/CC
classified/VBN
into/IN
4/CD
groups/NNS
./.
====================
In/IN
order/NN
to/TO
show/VB
the/DT
genes/NNS
’/CD
relevancy/NN
to/TO
angiogenesis/NN
,/,
seven/CD
of/IN
the/DT
26/CD
genes/NNS
were/VBD
investigated/VBN
to/TO
see/VB
whether/IN
they/PRP
have/VBP
capabilities/NNS
of/IN
interaction/NN
with/IN
angiogenesis-/NN
related/JJ
factors/NNS
in/IN
AngioDB/NN
./.
====================
Through/IN
this/DT
investigation/NN
,/,
====================
we/PRP
found/VBD
interactions/NNS
of/IN
three/CD
proteins/NNS
with/IN
angiogenesis-related/JJ
factors/NNS
./.
====================
These/DT
genes/NNS
were/VBD
further/RB
investigated/VBD
with/IN
a/DT
new/JJ
focus/NN
on/IN
the/DT
vascular/JJ
endothelial/JJ
growth/NN
factor/NN
(/(
VEGF/NN
)/)
expression/NN
in/IN
an/DT
astrocyte/NN
based/VBN
on/IN
our/PRP$
hypothesis/NN
that/IN
astrocytes/NNS
can/MD
have/VB
effects/NNS
on/IN
endothelial/JJ
angiogenesis/NN
via/IN
the/DT
release/NN
of/IN
VEGF/NN
./.
====================
Collectively/RB
,/,
we/PRP
identified/VBD
several/JJ
genes/NNS
whose/WP$
expressions/NNS
were/VBD
dependent/JJ
on/IN
the/DT
oxygen/NN
concentration/NN
of/IN
the/DT
astrocyte/NN
./.
====================
Furthermore/RB
,/,
the/DT
relevancy/NN
of/IN
astrocytes/NNS
to/TO
angiogenesis/NN
was/VBD
investigated/VBN
using/VBG
preexisting/VBG
information/NN
of/IN
AngioDB/NN
,/,
and/CC
suggested/VBD
a/DT
possible/JJ
signaling/NN
pathway/NN
for/IN
VEGF/NN
expression/NN
in/IN
the/DT
aspects/NNS
of/IN
brain/NN
endothelial/JJ
angiogenesis/NN
by/IN
astrocytes/NNS
./.
====================
Astrocytes/NNS
,/,
the/DT
most/JJS
numerous/JJ
glial/JJ
cells/NNS
,/,
have/VBP
been/VBN
regarded/VBN
as/IN
the/DT
supportive/JJ
cells/NNS
of/IN
the/DT
brain/NN
./.
====================
They/PRP
aid/VBP
neurons/NNS
in/IN
maintaining/VBG
a/DT
good/JJ
condition/NN
through/IN
nourishing/JJ
,/,
protecting/VBG
,/,
and/CC
modulating/VBG
growth/NN
and/CC
excitability/NN
(/(
Travis/NN
,/,
1994/CD
)/)
./.
====================
They/PRP
also/RB
function/VBP
as/IN
scavengers/NNS
that/DT
rapidly/RB
capture/NN
transmitters/NNS
that/DT
are/VBP
released/VBN
during/IN
synaptic/JJ
activity/NN
./.
====================
It/PRP
was/VBD
also/RB
reported/VBD
that/IN
some/DT
types/NNS
of/IN
astrocytes/NNS
can/MD
protect/VB
neurons/NNS
from/IN
oxidative/JJ
stress/NN
(/(
Shih/NN
et/FW
al./FW
,/,
2003/CD
)/)
./.
====================
Moreover/RB
,/,
astrocytes/NNS
are/VBP
known/VBN
to/TO
have/VB
various/JJ
important/JJ
roles/NNS
that/WDT
are/VBP
related/JJ
to/TO
the/DT
vascular/JJ
system/NN
as/IN
well/RB
as/IN
being/VBG
related/JJ
to/TO
the/DT
supportive/JJ
roles/NNS
for/IN
neuron/NN
growth/NN
and/CC
maintenance/NN
./.
====================
Therefore/RB
,/,
astrocytes/NNS
have/VBP
come/VBN
to/TO
be/VB
known/VBN
as/IN
“/CD
the/DT
bridge/NN
”/NN
between/IN
the/DT
nervous/JJ
and/CC
vascular/JJ
systems/NNS
(/(
Parri/NN
et/FW
al./FW
,/,
2003/CD
)/)
./.
====================
In/IN
fact/NN
,/,
astrocytes/NNS
are/VBP
in/IN
contact/NN
with/IN
both/CC
neuronal/JJ
synapses/NNS
and/CC
microvessels/NNS
./.
====================
For/IN
instance/NN
,/,
signaling/VBG
that/DT
involves/VBZ
the/DT
glutamate/NN
and/CC
calcium/NN
ions/NNS
between/IN
the/DT
neuron/NN
and/CC
astrocyte/NN
is/VBZ
a/DT
significant/JJ
factor/NN
in/IN
the/DT
control/NN
of/IN
brain/NN
microcirculation/NN
(/(
Zonta/NN
et/FW
al./FW
,/,
2003/CD
)/)
./.
====================
Astrocytes/NNS
are/VBP
also/RB
involved/VBN
in/IN
the/DT
process/NN
of/IN
blood-brain/NN
barrier/NN
(/(
BBB/NN
)/)
differentiation/NN
./.
====================
BBB/NN
is/VBZ
a/DT
well-differentiated/JJ
network/NN
of/IN
brain/NN
microvessels/NNS
that/DT
provides/VBZ
homeostasis/NN
./.
====================
It/PRP
is/VBZ
known/VBN
that/IN
BBB/NN
development/NN
can/MD
be/VB
classified/VBN
into/IN
brain/NN
angiogenesis/NN
and/CC
BBB/NN
differentiation/NN
./.
====================
Brain/RB
capillaries/NNS
go/NN
through/IN
differentiation/NN
with/IN
the/DT
astrocyte/NN
,/,
and/CC
these/DT
capillaries/NNS
become/VBP
more/RBR
mature/JJ
and/CC
are/VBP
remodeled/VBN
into/IN
a/DT
BBB/NN
that/DT
is/VBZ
impermeable/JJ
(/(
Janzer/NN
et/FW
al/JJ
„/CD
1987/CD
,/,
Lee/NNP
et/FW
a/DT
!/JJ
„/CD
2003/CD
)/)
./.
====================
Astrocytes/NNS
can/MD
be/VB
involved/VBN
in/IN
both/CC
the/DT
nervous/JJ
system/NN
and/CC
the/DT
vascular/JJ
system/NN
./.
====================
Recently/RB
,/,
many/JJ
neurobiologists/NNS
and/CC
vascular/JJ
biologists/NNS
have/VBP
been/VBN
interested/VBN
in/IN
the/DT
coordinated/VBN
interaction/NN
between/IN
the/DT
vascular/JJ
and/CC
nervous/JJ
systems/NNS
(/(
Park/NN
et/FW
a/DT
!/JJ
„/CD
2003/CD
)/)
./.
====================
Herein/RB
,/,
we/PRP
held/VBP
an/DT
anatomical/JJ
and/CC
functional/JJ
focus/NN
in/IN
exploring/VBG
the/DT
characteristics/NNS
of/IN
astrocytes/NNS
that/WDT
could/MD
be/VB
the/DT
linker/NN
between/IN
the/DT
two/CD
different/JJ
systems/NNS
./.
====================
Oxygen/NN
tension/NN
plays/VBZ
a/DT
crucial/JJ
role/NN
in/IN
the/DT
vascular/JJ
development/NN
(/(
Maltepe/NN
et/FW
al/JJ
„/CD
1998/CD
)/)
./.
====================
Angiogenesis/NN
,/,
which/WDT
is/VBZ
the/DT
process/NN
of/IN
new/JJ
vessel/NN
formation/NN
,/,
is/VBZ
very/RB
tightly/RB
controlled/VBN
by/IN
oxygen/NN
concentration/NN
levels/NNS
./.
====================
Therefore/RB
,/,
we/PRP
hypothesized/VBD
that/IN
oxygen/NN
tension/NN
would/MD
be/VB
a/DT
key/JJ
factor/NN
in/IN
gene/NN
expression/NN
of/IN
astrocytes/NNS
that/WDT
can/MD
be/VB
a/DT
part/NN
of/IN
the/DT
vascular/JJ
system/NN
as/IN
well/RB
as/IN
the/DT
nervous/JJ
system/NN
./.
====================
Moreover/RB
,/,
it/PRP
is/VBZ
expected/VBN
that/DT
some/DT
genes/NNS
in/IN
the/DT
astrocyte/NN
,/,
====================
which/WDT
illustrated/VBD
different/JJ
expression/NN
patterns/NNS
in/IN
various/JJ
oxygen/NN
conditions/NNS
,/,
could/MD
have/VB
an/DT
effect/NN
on/IN
angiogenesis/NN
of/IN
brain/NN
microvessels/NNS
./.
====================
Therefore/RB
,/,
a/DT
cDNA/NN
microarray/NN
was/VBD
performed/VBN
in/IN
order/NN
to/TO
screen/VB
genes/NNS
whose/WP$
expression/NN
level/NN
varied/VBD
according/VBG
to/TO
the/DT
oxygen/NN
conditions/NNS
including/VBG
normoxia/NN
(/(
normal/JJ
level/NN
of/IN
oxygen/NN
)/)
,/,
hypoxia/NN
(/(
low/JJ
level/NN
of/IN
oxygen/NN
)/)
,/,
and/CC
reoxygenation/NN
(/(
recovery/RB
of/IN
oxygen/NN
level/NN
)/)
./.
====================
Among/IN
the/DT
selected/VBN
genes/NNS
,/,
Smad4/NN
,/,
p62/NN
,/,
and/CC
Bcl-2/NN
associated/VBN
death/NN
promoter/NN
(/(
BAD/NN
)/)
were/VBD
investigated/VBN
using/VBG
some/DT
factors/NNS
in/IN
AngioDB/NN
in/IN
order/NN
to/TO
examine/VB
their/PRP$
interaction/NN
with/IN
angiogenesis-related/JJ
proteins/NNS
./.
====================
AngioDB/NN
is/VBZ
the/DT
database/NN
that/DT
consists/VBZ
of/IN
angiogenesis-related/JJ
molecules/NNS
and/CC
their/PRP$
signaling/NN
networks/NNS
(/(
Sohn/NN
et/FW
a/DT
!/JJ
„/CD
2002/CD
)/)
./.
====================
The/DT
list/NN
of/IN
angiogenesis-related/JJ
molecules/NNS
in/IN
AngioDB/NN
was/VBD
used/VBN
,/,
and/CC
it/PRP
was/VBD
focused/VBN
on/IN
the/DT
VEGF/NN
signaling/NN
networks/NNS
based/VBN
on/IN
the/DT
fact/NN
that/IN
it/PRP
is/VBZ
a/DT
key/JJ
factor/NN
in/IN
the/DT
induction/NN
of/IN
angiogenesis/NN
./.
====================
A/DT
rat/NN
lung/NN
epithelial/JJ
cell/NN
line/NN
(/(
L2/NN
)/)
as/IN
the/DT
control/NN
group/NN
in/IN
the/DT
microarray/NN
hybridization/NN
was/VBD
cultured/VBN
in/IN
RPMI/NN
1640/CD
with/IN
10/CD
%/NN
FBS/NN
(/(
Life/NN
Technologies/NNS
)/)
,/,
100/CD
U/ml/NN
penicillin/NN
streptomycin/NN
./.
====================
Culture/NN
environment/NN
of/IN
L2/NN
cell/NN
line/NN
was/VBD
maintained/VBN
at/IN
37/CD
C./FW
An/DT
immortalized/VBN
rat/NN
astrocyte/NN
cell/NN
line/NN
was/VBD
cultured/VBN
in/IN
DMEM/NN
supplemented/VBN
with/IN
10/CD
%/NN
FBS/NN
(/(
Life/NN
Technologies/NNS
)/)
,/,
20/CD
mM/NN
Sodium/NN
bicarbonate/NN
,/,
and/CC
100/CD
U/ml/NN
penicillin/NN
streptomycin/NN
./.
====================
Hypoxic/JJ
condition/NN
was/VBD
maintained/VBN
in/IN
a/DT
hypoxia/NN
chamber/NN
(/(
Forma/NN
Scientific/JJ
)/)
that/WDT
provided/VBD
a/DT
low/JJ
oxygen/NN
tension/NN
(/(
5/CD
%/NN
CO2/NN
with/IN
1/CD
%/NN
O2/CD
,/,
balanced/JJ
with/IN
N2/NN
)/)
for/IN
hypoxic/JJ
condition/NN
./.
====================
After/IN
exposure/NN
to/TO
hypoxia/NN
,/,
they/PRP
were/VBD
returned/VBN
to/TO
the/DT
ambient/JJ
atmosphere/VBP
,/,
supplied/VBD
with/IN
fresh/JJ
medium/NN
and/CC
continuously/RB
incubated/VBN
for/IN
the/DT
condition/NN
of/IN
reoxygenation/NN
./.
====================
Fig/NN
./.
====================
1/CD
shows/VBZ
experimental/JJ
scheme/NN
./.
====================
Each/DT
experiment/NN
was/VBD
done/VBN
in/IN
tripicates/NNS
./.
====================
The/DT
duration/NN
of/IN
hypoxia/NN
was/VBD
for/IN
16/CD
h./FW
The/DT
temperature/NN
in/IN
hypoxia/NN
was/VBD
maintained/VBN
at/IN
37°/CD
C./FW
In/IN
this/DT
case/NN
,/,
RNA/NN
isolation/NN
time/NN
point/NN
was/VBD
adapted/VBN
to/TO
different/JJ
periods/NNS
of/IN
reoxygenation/NN
(/(
0.5/CD
h/NN
,/,
9/CD
h/NN
)/)
./.
====================
RNA/NN
was/VBD
extracted/VBN
by/IN
standard/JJ
methods/NNS
./.
====================
Cells/NNS
were/VBD
lysed/VBN
using/VBG
TRIzol/NN
reagent/JJ
(/(
Life/NN
Technologies/NNS
)/)
,/,
and/CC
total/JJ
RNA/NN
was/VBD
isolated/VBN
according/VBG
to/TO
the/DT
manufacturer/NN
’/CD
s/NNS
instructions/NNS
./.
====================
Extracted/JJ
RNA/NN
was/VBD
subjected/VBN
to/TO
further/RBR
purification/NN
using/VBG
and/CC
RNeasy/NN
mini/NNS
kit/NN
(/(
Quiagen/NN
)/)
./.
====================
The/DT
quality/NN
and/CC
quantity/NN
of/IN
extracted/VBN
total/JJ
RNA/NN
samples/NNS
were/VBD
evaluated/VBN
by/IN
loading/VBG
a/DT
specific/JJ
amount/NN
of/IN
each/DT
sample/NN
on/IN
a/DT
denaturating/JJ
agarose/NN
gel/NN
./.
====================
Microarray/NN
experiment/NN
was/VBD
performed/VBN
according/VBG
to/TO
the/DT
technical/JJ
manual/JJ
of/IN
DNA/NN
dendrimer/NN
probe/NN
reagents/NNS
(/(
3DNA™/CD
Array/NN
50™/CD
Expression/NN
Array/NN
Detection/NN
reagents/NNS
,/,
Genisphere/NNP
)/)
./.
====================
Each/DT
RNA/NN
and/CC
Cy3/NN
or/CC
Cy5/NN
capture/NN
sequence/NN
primers/NNS
were/VBD
incubated/VBN
for/IN
10/CD
min/NN
at/IN
80°/CD
C./FW
At/IN
42°/CD
C/NN
an/DT
equal/JJ
volume/NN
of/IN
reaction/NN
mix/JJ
was/VBD
added/VBN
,/,
and/CC
the/DT
reaction/NN
was/VBD
incubated/VBN
2/CD
h./FW
The/DT
reaction/NN
was/VBD
terminated/VBN
by/IN
bringing/VBG
it/PRP
to/TO
0.074/CD
N/NN
NaOH/NN
and/CC
7.4/CD
mM/NN
EDTA/NN
./.
====================
Concentrated/JJ
cDNA/NN
tagged/VBN
with/IN
capture/NN
sequence/NN
was/VBD
mixed/VBN
with/IN
hybridization/NN
buffer/NN
(/(
40/CD
%/NN
formamide/NN
,/,
4x/NN
SSC/NN
,/,
1/CD
%/NN
SDS/NN
)/)
./.
====================
The/DT
mixture/NN
was/VBD
hybridized/VBN
to/TO
GeneTrack/NN
rat/NN
arrays/NNS
(/(
GenomicTree/NNP
)/)
,/,
which/WDT
contained/VBD
more/RBR
than/IN
5000/CD
of/IN
genes/NNS
and/CC
expressed/VBD
sequence/NN
tags/NNS
./.
====================
After/IN
incubation/NN
at/IN
45°/CD
C/NN
overnight/JJ
,/,
the/DT
arrays/NNS
were/VBD
washed/VBN
and/CC
dried/VBD
./.
====================
Then/RB
,/,
3DNA/NN
Array/NN
50/CD
Cy3/NN
and/CC
Cy5/NN
reagents/NNS
(/(
Genisphere/NNP
)/)
was/VBD
hybridized/VBN
to/TO
the/DT
arrays/NNS
and/CC
incubated/VBN
at/IN
50°/CD
C/NN
for/IN
3/CD
h./NN
After/IN
hybridization/NN
,/,
the/DT
arrays/NNS
were/VBD
washed/VBN
and/CC
dried/VBD
./.
====================
The/DT
hybridized/VBN
probe/NN
array/NN
was/VBD
scanned/VBN
by/IN
microarray/NN
scanner/NN
GenePix/NN
4000B/NN
(/(
Axon/JJ
Instruments/NNS
)/)
with/IN
GenePix/NN
Pro/NN
4.0/CD
(/(
Axon/JJ
Instruments/NNS
)/)
as/IN
analysis/NN
software/RB
./.
====================
GenePix/NN
Pro/NN
4.0/CD
performed/VBN
global/JJ
normalization/NN
every/RB
scanning/NN
./.
====================
R/NN
(/(
http/NN
:/:
///CD
www.r-project.org/NN
)/)
was/VBD
used/VBN
in/IN
normalization/NN
of/IN
all/DT
arrays/NNS
./.
====================
We/PRP
used/VBD
J-Express/JJ
to/TO
cluster/NN
and/CC
generate/VBP
candidates/NNS
whose/WP$
expression/NN
would/MD
be/VB
changed/VBN
by/IN
oxygen/NN
tension/NN
(/(
http/NN
:/:
//www.ii.uib.no//JJ
~/CD
bjarted/jexpress//IN
)/)
./.
====================
Gene/NN
expression/NN
profiles/NNS
from/IN
the/DT
four/CD
different/JJ
oxygen/NN
conditions/NNS
were/VBD
analyzed/VBN
using/VBG
the/DT
self-organizing/JJ
map/VBP
(/(
SOM/NN
)/)
algorithm/NN
./.
====================
We/PRP
constructed/VBD
a/DT
16—partition/NN
SOM/NN
(/(
data/NNS
====================
not/RB
shown/VBN
)/)
./.
====================
A/DT
16—partition/NN
SOM/NN
represented/VBN
distinguishable/JJ
expression/NN
pattern/NN
between/IN
clusters/NNS
./.
====================
Next/RB
,/,
we/PRP
selected/VBD
only/RB
4/CD
groups/NNS
of/IN
the/DT
gene/NN
expression/NN
====================
patterns/NNS
that/WDT
were/VBD
thought/VBN
to/TO
be/VB
biologically/RB
meaningful/JJ
:/:
increased/VBD
at/IN
hypoxia/NN
;/:
decreased/VBD
at/IN
hypoxia/NN
and/CC
recovered/VBD
at/IN
reoxygenation/NN
;/:
increased/VBD
at/IN
early/JJ
reoxygenation/NN
(/(
30/CD
min/NN
reoxygenation/NN
after/IN
exposure/NN
to/TO
hypoxia/NN
)/)
;/:
decreased/VBD
at/IN
early/JJ
reoxygenation/NN
./.
====================
After/IN
selection/NN
of/IN
4/CD
groups/NNS
,/,
we/PRP
found/VBD
the/DT
genes/NNS
among/IN
them/PRP
whose/WP$
expression/NN
was/VBD
more/RBR
sensitive/JJ
to/TO
oxygen/NN
tension/NN
under/IN
the/DT
criteria/NNS
:/:
1/CD
)/)
ratio/NN
was/VBD
>/JJR
2.0-fold/RB
as/IN
increased/VBN
,/,
2/CD
)/)
</JJR
0.5-fold/JJ
as/IN
decreased/VBN
./.
====================
As/IN
shown/VBN
in/IN
Table/JJ
1/CD
,/,
there/EX
are/VBP
26/CD
clones/NNS
whose/WP$
expressions/NNS
are/VBP
dramatically/RB
changed/VBD
by/IN
oxygen/NN
concentration/NN
./.
====================
The/DT
selected/VBN
genes/NNS
in/IN
the/DT
results/NNS
from/IN
microarray/NN
screening/NN
were/VBD
analyzed/VBN
using/VBG
the/DT
database/NN
,/,
AngioDB/NN
(/(
http/NN
:/:
//angiodb/NN
./.
====================
snu.ac.kr/RB
)/)
./.
====================
The/DT
analysis/NN
of/IN
interactions/NNS
was/VBD
based/VBN
on/IN
the/DT
information/NN
in/IN
PubMed/JJ
./.
====================
We/PRP
draw/VBP
the/DT
network/NN
using/VBG
Cytoscape/NN
(/(
http/NN
:/:
//cytoscape.org/JJ
)/)
,/,
which/WDT
is/VBZ
a/DT
bioinformatics/NNS
software/JJ
platform/NN
for/IN
visualizing/VBG
molecular/JJ
interaction/NN
networks/NNS
./.
====================
Twenty-six/CD
genes/NNS
from/IN
the/DT
cDNA/NN
microarray/NN
analysis/NN
were/VBD
selected/VBN
according/VBG
to/TO
the/DT
criteria/NNS
described/VBN
in/IN
the/DT
Methods/NNS
./.
====================
In/IN
Table/JJ
1/CD
,/,
the/DT
expression/NN
level/NN
was/VBD
represented/VBN
as/IN
the/DT
relative/JJ
ratio/NN
to/TO
the/DT
level/NN
at/IN
normoxia/NN
./.
====================
To/TO
study/VB
relevancy/NN
of/IN
the/DT
factors/NNS
involved/VBN
in/IN
angiogenesis/NN
,/,
an/DT
investigation/NN
of/IN
interactions/NNS
was/VBD
performed/VBN
using/VBG
the/DT
data/NNS
in/IN
AngioDB/NN
./.
====================
AngioDB/NN
is/VBZ
a/DT
database/NN
of/IN
angiogenesis/NN
and/CC
====================
angiogenesis-related/JJ
molecules/NNS
in/IN
human/JJ
,/,
which/WDT
includes/VBZ
identification/NN
,/,
functional/JJ
classification/NN
,/,
and/CC
bibliographic/JJ
references/VBZ
./.
====================
The/DT
known/JJ
genes/NNS
were/VBD
the/DT
center/NN
of/IN
focus/NN
because/IN
we/PRP
analyzed/VBD
interactions/NNS
using/VBG
preexisting/VBG
information/NN
in/IN
PubMed/JJ
./.
====================
Therefore/RB
,/,
among/IN
the/DT
26/CD
genes/NNS
,/,
15/CD
ESTs/NNS
were/VBD
excluded/VBN
at/IN
the/DT
beginning/VBG
of/IN
the/DT
analysis/NN
./.
====================
Then/RB
,/,
some/DT
genes/NNS
that/WDT
were/VBD
thought/VBN
to/TO
be/VB
appropriate/JJ
for/IN
this/DT
analysis/NN
were/VBD
selected/VBN
among/IN
the/DT
rest/JJS
of/IN
the/DT
11/CD
known/VBN
genes/NNS
,/,
which/WDT
encode/VBP
for/IN
PMF31/NN
,/,
inhibitor/NN
of/IN
DNA/NN
binding/NN
1/CD
(/(
Id—1/NN
)/)
,/,
Smad4/JJ
,/,
PKC-f/JJ
-interacting/JJ
protein/NN
(/(
ZIP/NN
)/)
,/,
CL3BC/NN
,/,
BAD/NN
,/,
ADP-ribosylation/NN
factor-like/JJ
1/CD
(/(
ARL1/NN
)/)
,/,
elF-2B/NN
a/DT
subunit/NN
,/,
NGF-inducible/JJ
anti-/JJ
proliferative/JJ
protein/NN
PC3/NN
(/(
PC3/NN
)/)
,/,
Regulator/NN
G/NN
protein/NN
signaling/VBG
8/CD
(/(
RGS8/NN
)/)
,/,
and/CC
Stat5B/NN
./.
====================
Among/IN
these/DT
,/,
PMF31/NN
and/CC
CL3BC/NN
were/VBD
excluded/VBN
because/IN
human/JJ
homologs/NNS
can/MD
not/RB
be/VB
found/VBN
./.
====================
Additionally/RB
,/,
inhibitor/NN
of/IN
DNA/NN
binding/NN
1/CD
and/CC
Stat5B/NN
were/VBD
also/RB
excluded/VBN
for/IN
our/PRP$
study/NN
because/IN
they/PRP
were/VBD
already/RB
well/RB
reported/VBN
to/TO
be/VB
involved/VBN
in/IN
angiogenic/JJ
pathways/NNS
(/(
Benezra/NN
et/FW
a/DT
!/JJ
./.
,/,
2001/CD
;/:
Dentelli/NNP
et/FW
====================
al/JJ
„/CD
1999/CD
)/)
./.
====================
Finally/RB
,/,
7/CD
genes/NNS
for/IN
the/DT
interaction/NN
analysis/NN
were/VBD
selected/VBN
:/:
S/rao^and/CC
p£2in/NN
the/DT
group/NN
of/IN
genes/NNS
that/WDT
increased/VBD
at/IN
hypoxia/NN
;/:
BAD/NN
,/,
ARL1/NN
,/,
e/NN
!/CD
F-2B/NN
a-subunit/NN
,/,
PC3/NN
,/,
and/CC
RGS8/NN
in/IN
the/DT
group/NN
of/IN
genes/NNS
that/WDT
increased/VBD
during/IN
early/JJ
reoxygenation/NN
./.
====================
In/IN
analyzing/VBG
the/DT
interactions/NNS
with/IN
angiogenesis-related/JJ
factors/NNS
,/,
the/DT
results/NNS
indicate/VBP
that/IN
4/CD
out/RB
of/IN
7/CD
proteins/NNS
,/,
ARL1/NN
,/,
elF-2B/NN
^subunit/NN
,/,
PC3/NN
,/,
and/CC
RGS8/NN
,/,
had/VBD
no/DT
interaction/NN
with/IN
factors/NNS
stored/VBD
in/IN
AngioDB/NN
./.
====================
Fig/NN
./.
====================
2/CD
shows/VBZ
the/DT
primary/JJ
interactions/NNS
of/IN
the/DT
remaining/VBG
three/CD
proteins/NNS
,/,
Smad4/NN
,/,
p62/NN
,/,
and/CC
BAD/NN
,/,
with/IN
angiogenesis-related/JJ
factors/NNS
./.
====================
According/VBG
to/TO
this/DT
interaction/NN
analysis/NN
,/,
Smad4/JJ
interacts/VBZ
with/IN
7/CD
angiogenesis/NN
-related/JJ
factors/NNS
:/:
Sp1/NN
,/,
TGF-//NNP
?/.
,/,
Jun/NN
,/,
UBC9/NNP
,/,
CREB/NN
,/,
Jab1/NNP
,/,
and/CC
haptoglobin/NN
;/:
p62/NN
interacts/VBZ
with/IN
p53/NN
,/,
angiotensin/NN
,/,
TrkA/NNP
,/,
Fos/NN
,/,
PKC/NN
,/,
epidermal/JJ
growth/NN
factor/NN
receptor/NN
(/(
EGFR/NN
)/)
,/,
NF-/cB/JJ
,/,
Ras/NN
,/,
and/CC
Spl/NN
;/:
BAD/NNP
interacts/VBZ
with/IN
eight/CD
other/JJ
proteins/NNS
:/:
TGF-0/NN
,/,
IL2/NN
,/,
HBx/NNP
,/,
haptoglobin/RB
,/,
PKC/NN
,/,
NF-/cB/JJ
,/,
BRCA/NN
1/CD
,/,
and/CC
nerve/NN
growth/NN
factor/NN
(/(
NGF/NN
)/)
./.
====================
Above/JJ
,/,
it/PRP
was/VBD
found/VBN
that/IN
molecules/NNS
are/VBP
involved/VBN
in/IN
angiogenesis/NN
and/CC
they/PRP
interact/VBP
with/IN
candidates/NNS
that/DT
resulted/VBD
from/IN
the/DT
cDNA/NN
microarray/NN
analysis/NN
by/IN
using/VBG
preexisting/VBG
information/NN
from/IN
AngioDB/NN
without/IN
additional/JJ
biological/JJ
experiments/NNS
./.
====================
It/PRP
would/MD
be/VB
possible/JJ
to/TO
further/RBR
study/NN
these/DT
factors/NNS
in/IN
order/NN
to/TO
discover/JJ
the/DT
role/NN
in/IN
angiogenesis/NN
./.
====================
However/RB
,/,
such/JJ
that/IN
trial/JJ
would/MD
be/VB
still/RB
arduous/JJ
;/:
because/IN
it/PRP
needs/VBZ
to/TO
screen/VB
a/DT
wide/JJ
range/NN
of/IN
possibilities/NNS
that/DT
could/MD
be/VB
considered/VBN
as/IN
elucidating/VBG
an/DT
obvious/JJ
relationship/NN
between/IN
the/DT
gene/NN
expression/NN
in/IN
the/DT
astrocyte/NN
and/CC
brain/NN
angiogenesis/NN
./.
====================
If/IN
astrocytes/NNS
represent/VBP
the/DT
effect/NN
of/IN
angiogenesis/NN
on/IN
endothelial/JJ
cells/NNS
,/,
one/CD
of/IN
the/DT
possible/JJ
paths/NNS
for/IN
regulating/VBG
angiogenesis/NN
can/MD
be/VB
the/DT
secretion/NN
of/IN
VEGF/NN
,/,
an/DT
endothelial/JJ
cell-specific/JJ
mitogen/NN
that/DT
plays/VBZ
an/DT
important/JJ
role/NN
in/IN
angiogenesis/NN
./.
====================
Herein/RB
,/,
the/DT
factors/NNS
that/WDT
can/MD
act/VB
on/IN
the/DT
expression/NN
of/IN
====================
VEGF/NN
were/VBD
extracted/VBN
from/IN
the/DT
data/NNS
in/IN
AngioDB/NN
,/,
and/CC
then/RB
,/,
the/DT
factors/NNS
interacting/VBG
with/IN
Smad4/NN
,/,
p62/NN
,/,
and/CC
BAD/NN
were/VBD
investigated/VBN
./.
====================
The/DT
focus/NN
was/VBD
on/IN
primary/JJ
interactions/NNS
of/IN
Smad4/NN
,/,
p62/NN
,/,
and/CC
BAD/NN
with/IN
the/DT
factors/NNS
that/WDT
influence/VBP
VEGF/NN
expression/NN
./.
====================
As/IN
shown/VBN
in/IN
Fig/NN
./.
====================
3/CD
,/,
we/PRP
integrated/VBD
interactions/NNS
and/CC
constructed/VBD
the/DT
networks/NNS
./.
====================
Smad4/NN
can/MD
act/VB
on/IN
VEGF/NN
expression/NN
via/IN
Sp1/NN
and/CC
TGF-//NN
?/.
====================
;/:
p62/NN
can/MD
do/VBP
the/DT
same/JJ
via/IN
angiotensin/NN
,/,
Ras/NN
,/,
PKC/NN
,/,
and/CC
Sp1/NN
./.
====================
The/DT
interaction/NN
of/IN
BAD/NN
was/VBD
different/JJ
from/IN
those/DT
of/IN
Smad4/NN
and/CC
p62/NN
./.
====================
On/IN
the/DT
interaction/NN
network/NN
,/,
it/PRP
was/VBD
impossible/JJ
to/TO
be/VB
linked/VBN
via/IN
only/RB
one/CD
factor/NN
from/IN
BAD/NN
to/TO
VEGF/NN
./.
====================
There/EX
were/VBD
only/RB
two/CD
angiogenesis-related/JJ
factors/NNS
,/,
NF-/cB/NN
and/CC
IL2/NN
,/,
receiving/VBG
a/DT
signal/NN
from/IN
BAD/NN
on/IN
the/DT
interaction/NN
network/NN
./.
====================
These/DT
proteins/NNS
did/VBD
not/RB
have/VB
a/DT
direct/JJ
effect/NN
on/IN
VEGF/NN
on/IN
the/DT
network/NN
./.
====================
Therefore/RB
,/,
further/RB
investigation/NN
of/IN
primary/JJ
interactions/NNS
for/IN
NF-/NN
k/NN
B/NN
and/CC
IL2/NN
was/VBD
performed/VBN
because/IN
it/PRP
was/VBD
expected/VBN
that/DT
there/EX
would/MD
be/VB
some/DT
linkages/NNS
to/TO
VEGF/NN
among/IN
interactions/NNS
with/IN
other/JJ
factors/NNS
that/WDT
were/VBD
involved/VBN
in/IN
angiogenesis/NN
./.
====================
The/DT
network/NN
in/IN
Fig/NN
./.
====================
4/CD
shows/VBZ
interactions/NNS
concentrating/VBG
on/IN
NF-/cB/NN
,/,
IL2/NN
,/,
and/CC
the/DT
relationship/NN
with/IN
factors/NNS
that/WDT
directly/RB
interact/VB
with/IN
VEGF/NN
./.
====================
Based/VBN
on/IN
the/DT
networks/NNS
,/,
we/PRP
inferred/VBD
which/WDT
signaling/NN
pathways/NNS
Smad4/NN
,/,
p62/NN
and/CC
BAD/NN
were/VBD
involved/VBN
in/IN
(/(
Table/JJ
2/CD
)/)
./.
====================
First/RB
,/,
Smads/VBZ
protein/NN
is/VBZ
involved/VBN
in/IN
the/DT
TGF-//NN
?/.
====================
signaling/NN
pathway/NN
(/(
Derynck/NN
et/FW
a//FW
„/CD
1998/CD
)/)
./.
====================
Reportedly/RB
,/,
TGF-0/NN
has/VBZ
the/DT
effect/NN
of/IN
angiogenesis-activation/NN
(/(
Roberts/NNS
et/FW
al/JJ
„/CD
1986/CD
)/)
./.
====================
Presumption/NN
for/IN
Smad4/NN
,/,
however/RB
,/,
is/VBZ
somehow/RB
complex/NN
./.
====================
Smad4/NN
plays/VBZ
a/DT
pivotal/JJ
role/NN
affecting/VBG
all/DT
TGF-//NN
?/.
====================
signaling/NN
and/CC
also/RB
has/VBZ
a/DT
tumor/NN
suppressor/NN
effect/NN
./.
====================
Additionally/RB
,/,
while/IN
TGF-//NN
?/.
====================
also/RB
has/VBZ
other/JJ
attributes/NNS
to/TO
inhibit/VB
epithelial/JJ
cell/NN
growth/NN
,/,
induce/VBP
differentiation/NN
or/CC
apoptosis/NN
,/,
and/CC
maintain/VBP
genomic/JJ
stability/NN
(/(
Howe/NNP
et/FW
a/./FW
,/,
1998/CD
)/)
,/,
TGF-0/NN
has/VBZ
a/DT
neuroprotective/JJ
effect/NN
by/IN
blocking/VBG
apoptosis/NN
through/IN
phosphorylation/NN
of/IN
BAD/NN
(/(
Zhu/NNP
et/FW
a/DT
!/JJ
./.
,/,
2002/CD
)/)
./.
====================
Therefore/RB
,/,
the/DT
output/NN
of/IN
Smad4/NN
and/CC
TGF-0/NN
signaling/NN
depends/VBZ
on/IN
various/JJ
physiological/JJ
phenomena/NNS
and/CC
cell/NN
types/NNS
./.
====================
For/IN
our/PRP$
analysis/NN
,/,
the/DT
focus/NN
was/VBD
on/IN
the/DT
interactions/NNS
that/WDT
would/MD
be/VB
involved/VBN
in/IN
VEGF/NN
expression/NN
when/WRB
the/DT
oxygen/NN
condition/NN
was/VBD
altered/JJ
./.
====================
Sp/JJ
1/CD
was/VBD
reported/VBN
to/TO
activate/VB
VEGF/NN
transcription/NN
(/(
Reisinger/NN
et/FW
al./FW
,/,
2003/CD
)/)
,/,
and/CC
Smad4/NN
associates/VBZ
with/IN
and/CC
positively/RB
interacts/VBZ
with/IN
Sp1/NN
(/(
Pardali/NN
et/FW
al/JJ
„/CD
2000/CD
)/)
./.
====================
Therefore/RB
,/,
Smad4/NN
can/MD
mediate/VB
TGF-/NN
0/CD
signaling/NN
in/IN
VEGF/NN
expression/NN
,/,
or/CC
Smad4/NN
can/MD
be/VB
the/DT
upstream/JJ
factor/NN
for/IN
Sp1-mediated/JJ
VEGF/NN
induction/NN
./.
====================
Taken/VBN
together/RB
,/,
Smad4/NN
,/,
whose/WP$
mRNA/NN
level/NN
was/VBD
increasingly/RB
expressed/VBN
at/IN
hypoxia/NN
,/,
is/VBZ
possibly/RB
involved/VBN
in/IN
the/DT
induction/NN
of/IN
VEGF/NN
via/IN
interactions/NNS
with/IN
Sp1/NN
and/CC
TGF-//NN
?/.
./.
====================
Furthermore/RB
,/,
in/IN
the/DT
long/JJ
run/JJ
,/,
it/PRP
can/MD
lead/VB
to/TO
endothelial/JJ
angiogenesis/NN
====================
by/IN
astrocytes/NNS
./.
====================
Second/RB
,/,
like/IN
Smad4/NN
,/,
ZIP/NN
was/VBD
also/RB
increased/VBD
at/IN
hypoxia/NN
in/IN
the/DT
results/NNS
of/IN
the/DT
microarrays/NNS
./.
====================
ZIP/NN
was/VBD
isolated/VBN
from/IN
a/DT
rat/NN
brain/NN
cDNA/NN
library/NN
and/CC
was/VBD
known/VBN
to/TO
interact/VB
with/IN
the/DT
regulatory/JJ
domain/NN
of/IN
PKC-f/JJ
(/(
Puls/NNS
et/FW
a/DT
!/JJ
„/CD
1997/CD
)/)
./.
====================
The/DT
human/JJ
ZIP/NN
homolog/NN
that/DT
encodes/VBZ
a/DT
cytosoilc/JJ
62-kDa/JJ
protein/NN
(/(
p62/NN
)/)
was/VBD
identified/VBN
and/CC
cloned/VBN
(/(
Park/NN
et/FW
a//FW
„/CD
1995/CD
)/)
./.
====================
As/IN
the/DT
result/NN
of/IN
the/DT
interaction/NN
network/NN
,/,
p62/NN
can/MD
induce/VB
the/DT
VEGF/NN
expression/NN
via/IN
interactions/NNS
with/IN
PKC/NN
,/,
Sp1/NN
,/,
angiotensin/NN
,/,
and/CC
Ras/NN
./.
====================
PKC-£/NN
is/VBZ
an/DT
intermediary/JJ
molecule/NN
for/IN
Ras-mediated/JJ
overexpression/NN
of/IN
VEGF/NN
(/(
Pal/JJ
et/FW
a/./FW
,/,
2001/CD
)/)
./.
====================
Conversely/RB
,/,
p62/NN
acts/VBZ
as/IN
a/DT
negative/JJ
regulator/NN
of/IN
Ras/NN
(/(
Di/NN
Cristofano/NN
et/FW
al./FW
,/,
2001/CD
)/)
./.
====================
Therefore/RB
,/,
p62/NN
is/VBZ
likely/JJ
to/TO
play/VB
a/DT
role/NN
as/IN
the/DT
decisive/JJ
regulator/NN
of/IN
PKC-f/JJ
signaling/NN
====================
for/IN
VEGF/NN
expression/NN
./.
====================
In/IN
addition/NN
to/TO
signaling/VBG
via/IN
PKC/NN
,/,
Sp1/NN
,/,
and/CC
Ras/NN
,/,
p62/NN
also/RB
interacts/VBZ
with/IN
angiotensin/NN
II/CD
,/,
which/WDT
has/VBZ
been/VBN
reported/VBN
to/TO
induce/VB
VEGF/NN
expression/NN
(/(
Rizkalla/NN
et/FW
at./FW
,/,
2003/CD
)/)
./.
====================
Moreover/RB
,/,
p62/NN
is/VBZ
associated/VBN
with/IN
angiotensin/NN
II/CD
and/CC
involved/VBN
in/IN
angiotensin/NN
Il-mediated/JJ
signaling/NN
(/(
Lu/NNP
et/FW
a/DT
!/JJ
„/CD
1998/CD
)/)
./.
====================
Therefore/RB
,/,
p62/NN
can/MD
be/VB
a/DT
regulator/NN
of/IN
either/CC
PKC-f-or/JJ
angiotensin/NN
II-/NN
mediated/VBN
signaling/NN
./.
====================
Finally/RB
,/,
BAD/NN
is/VBZ
a/DT
distant/JJ
member/NN
of/IN
the/DT
Bcl-2/NN
family/NN
of/IN
proteins/NNS
that/WDT
was/VBD
identified/VBN
as/IN
a/DT
Bcl-2-interacting/JJ
protein/NN
(/(
Yang/NNP
et/FW
a/DT
!/JJ
./.
,/,
1995/CD
)/)
./.
====================
Bcl2/NN
and/CC
Bcl-xL/NN
have/VBP
anti-apoptotic/JJ
effects/NNS
,/,
while/IN
other/JJ
members/NNS
of/IN
the/DT
Bcl-2/NN
====================
family/NN
,/,
such/JJ
as/IN
Bax/NN
and/CC
BAD/NN
are/VBP
pro-apoptotic/JJ
molecules/NNS
./.
====================
In/IN
terms/NNS
of/IN
the/DT
interaction/NN
network/NN
,/,
there/EX
was/VBD
not/RB
a/DT
path/NN
via/IN
only/RB
one/CD
factor/NN
from/IN
BAD/NN
to/TO
VEGF/NN
./.
====================
As/IN
shown/VBN
in/IN
Fig/NN
./.
====================
4/CD
,/,
there/EX
is/VBZ
a/DT
wider/RBR
range/NN
of/IN
molecules/NNS
involved/VBN
in/IN
the/DT
pathway/NN
from/IN
BAD/NN
to/TO
VEGF/NN
through/IN
the/DT
extension/NN
to/TO
the/DT
secondary/JJ
interaction/NN
of/IN
BAD/NN
via/IN
NF-/NN
k/NN
B/NN
and/CC
IL2/NN
./.
====================
From/IN
the/DT
results/NNS
of/IN
the/DT
microarray/NN
,/,
both/CC
Smad4/JJ
and/CC
p62/NN
were/VBD
increased/VBN
at/IN
hypoxia/NN
,/,
while/IN
BAD/NN
was/VBD
dramatically/RB
induced/VBD
at/IN
the/DT
stage/NN
of/IN
early/JJ
reoxygenation/NN
./.
====================
Considering/VBG
hypoxia/NN
is/VBZ
closely/RB
connected/VBD
with/IN
angiogenesis/NN
,/,
the/DT
fact/NN
that/IN
Smad4/NN
and/CC
p62/NN
were/VBD
expressed/VBN
notably/RB
at/IN
hypoxia/NN
====================
could/MD
be/VB
relevant/JJ
to/TO
the/DT
linkage/NN
state/NN
with/IN
VEGF/NN
in/IN
just/RB
a/DT
2-step/JJ
interaction/NN
because/IN
less/RBR
number/NN
of/IN
interactions/NNS
might/MD
generate/VB
a/DT
faster/JJ
effect/NN
on/IN
VEGF/NN
expression/NN
by/IN
upstream/JJ
factors/NNS
./.
====================
BAD/NN
being/VBG
increased/VBN
during/IN
early/JJ
reoxygenation/NN
is/VBZ
linked/VBN
to/TO
VEGF/NN
not/RB
in/IN
a/DT
2-step/JJ
but/CC
3-step/JJ
interaction/NN
./.
====================
It/PRP
is/VBZ
possible/JJ
for/IN
BAD/NN
to/TO
be/VB
linked/VBN
to/TO
VEGF/NN
in/IN
a/DT
3-step/JJ
interaction/NN
due/JJ
to/TO
NF-/cB/NN
and/CC
IL2/NN
,/,
which/WDT
are/VBP
major/JJ
factors/NNS
involving/VBG
many/JJ
interacting/VBG
proteins/NNS
./.
====================
It/PRP
means/NNS
that/IN
BAD/NN
induce/VBP
the/DT
VEGF/NN
expression/NN
via/IN
a/DT
number/NN
of/IN
pathways/NNS
,/,
but/CC
the/DT
specificity/NN
of/IN
BAD/NN
for/IN
VEGF/NN
expression/NN
might/MD
be/VB
reduced/VBN
because/IN
once/RB
BAD/NN
interacts/VBZ
with/IN
NF-/cB/JJ
and/CC
IL2/NN
,/,
which/WDT
interact/VBP
with/IN
a/DT
huge/JJ
number/NN
of/IN
molecules/NNS
in/IN
the/DT
various/JJ
biological/JJ
processes/NNS
,/,
the/DT
effect/NN
of/IN
BAD/NN
can/MD
possibly/RB
be/VB
dispersed/VBN
./.
====================
Recently/RB
,/,
astrocytes/NNS
have/VBP
become/VBN
the/DT
issue/NN
of/IN
interest/NN
because/IN
it/PRP
has/VBZ
been/VBN
reported/VBN
to/TO
have/VB
various/JJ
important/JJ
effects/NNS
on/IN
the/DT
vascular/JJ
system/NN
and/CC
the/DT
nervous/JJ
system/NN
./.
====================
The/DT
major/JJ
cell/NN
type/NN
involved/VBN
in/IN
this/DT
process/NN
is/VBZ
the/DT
endothelial/JJ
cell/NN
,/,
which/WDT
has/VBZ
surface/NN
receptors/NNS
to/TO
which/WDT
angiogenic/JJ
factors/NNS
bind/VBP
./.
====================
In/IN
the/DT
brain/NN
,/,
astrocytes/NNS
are/VBP
associated/VBN
with/IN
endothelial/JJ
cells/NNS
of/IN
the/DT
brain/NN
microvessels/NNS
as/IN
well/RB
as/IN
to/TO
the/DT
neurons/NNS
./.
====================
Based/VBN
on/IN
this/DT
concept/NN
that/IN
astrocytes/NNS
can/MD
influence/VB
the/DT
vascular/JJ
system/NN
,/,
the/DT
investigation/NN
of/IN
differential/JJ
gene/NN
expression/NN
in/IN
astrocytes/NNS
according/VBG
to/TO
oxygen/NN
tension/NN
is/VBZ
meaningful/JJ
./.
====================
Through/IN
the/DT
investigation/NN
of/IN
interactions/NNS
by/IN
using/VBG
the/DT
data/NNS
in/IN
AngioDB/NN
,/,
the/DT
candidate/NN
genes/NNS
,/,
which/WDT
resulted/VBD
from/IN
the/DT
microarray/NN
experiment/NN
,/,
were/VBD
suggested/VBN
to/TO
be/VB
involved/VBN
in/IN
angiogenesis-related/JJ
networks/NNS
./.
====================
To/TO
further/RBR
study/NN
the/DT
effects/NNS
on/IN
endothelial/JJ
angiogenesis/NN
,/,
we/PRP
hypothesized/VBD
that/IN
if/IN
astrocytes/NNS
release/NN
VEGF/NN
depending/VBG
on/IN
oxygen/NN
tension/NN
,/,
VEGF/NN
can/MD
induce/VB
brain/NN
angiogenesis/NN
around/IN
them/PRP
./.
====================
Therefore/RB
,/,
the/DT
effects/NNS
of/IN
Smad4/NN
,/,
p62/NN
,/,
and/CC
BAD/NN
on/IN
endothelial/JJ
angiogenesis/NN
were/VBD
judged/VBN
from/IN
their/PRP$
relationship/NN
with/IN
signaling/NN
pathways/NNS
that/WDT
are/VBP
relevant/JJ
to/TO
VEGF/NN
expression/NN
./.
====================
Smad4/NN
and/CC
p62/NN
,/,
which/WDT
were/VBD
increased/VBN
at/IN
hypoxia/NN
,/,
can/MD
lead/VB
to/TO
VEGF/NN
via/IN
just/RB
one/CD
factor/NN
,/,
such/JJ
as/IN
SP1/NN
,/,
Ras/NN
,/,
and/CC
so/RB
on/IN
./.
====================
On/IN
the/DT
other/JJ
hand/NN
,/,
BAD/NN
,/,
which/WDT
illustrated/VBD
very/RB
high/JJ
expression/NN
levels/NNS
during/IN
early/JJ
reoxygenation/NN
,/,
can/MD
influence/VB
VEGF/NN
expression/NN
in/IN
a/DT
3-step/JJ
interaction/NN
./.
====================
This/DT
shows/VBZ
that/IN
considering/VBG
oxygen/NN
deficiency/NN
is/VBZ
a/DT
crucial/JJ
factor/NN
for/IN
angiogenesis/NN
,/,
and/CC
Smad4/NN
and/CC
p62/NN
were/VBD
connected/VBN
more/RBR
closely/RB
with/IN
VEGF/NN
expression/NN
than/IN
BAD/NN
./.
====================
This/DT
also/RB
signifies/VBZ
that/DT
Smad4/NN
and/CC
p62/NN
increasing/VBG
at/IN
hypoxia/NN
can/MD
rapidly/RB
increase/regulate/VBP
VEGF/NN
expression/NN
./.
====================
In/IN
addition/NN
,/,
through/IN
the/DT
inference/NN
of/IN
the/DT
signaling/NN
pathway/NN
for/IN
VEGF/NN
expression/NN
,/,
it/PRP
is/VBZ
possible/JJ
to/TO
identify/VB
the/DT
underlying/VBG
mechanism/NN
of/IN
some/DT
phenomena/NNS
as/IN
well/RB
as/IN
the/DT
potential/JJ
signaling/VBG
pathways/NNS
in/IN
====================
angiogenesis/NN
./.
====================
For/IN
example/NN
,/,
both/CC
Smad4/NN
and/CC
p62/NN
can/MD
be/VB
linked/VBN
to/TO
Sp1/NN
./.
====================
VEGF/NN
expression/NN
by/IN
oxidative/JJ
stress/NN
was/VBD
known/VBN
to/TO
be/VB
mediated/VBN
by/IN
the/DT
Sp-1/NN
and/CC
Sp-3/NN
dependent/JJ
mechanism/NN
(/(
Schafer/NNP
et/FW
al/JJ
„/CD
2003/CD
)/)
./.
====================
Of/IN
these/DT
,/,
Smad4/NN
and/CC
p62/NN
,/,
which/WDT
are/VBP
sensitive/JJ
to/TO
oxygen/NN
tension/NN
,/,
can/MD
act/VB
as/IN
an/DT
intermediary/JJ
factor/NN
for/IN
Sp-1/NN
signaling/NN
that/DT
is/VBZ
related/JJ
to/TO
oxygen/NN
concentration/NN
./.
====================
For/IN
BAD/NN
,/,
instead/RB
of/IN
being/VBG
involved/VBN
in/IN
the/DT
shorter/JJR
signaling/NN
pathways/NNS
toward/IN
VEGF/NN
expression/NN
,/,
it/PRP
might/MD
be/VB
involved/VBN
in/IN
a/DT
number/NN
of/IN
interactions/NNS
with/IN
factors/NNS
having/VBG
effects/NNS
on/IN
VEGF/NN
expression/NN
via/IN
NF-/cB/JJ
and/CC
IL2/NN
./.
====================
Then/RB
,/,
it/PRP
can/MD
have/VB
effects/NNS
on/IN
various/JJ
signaling/NN
for/IN
other/JJ
processes/NNS
as/IN
well/RB
as/IN
for/IN
VEGF/NN
expression/NN
./.
====================
These/DT
inferences/NNS
would/MD
be/VB
applied/VBN
to/TO
other/JJ
phenomena/NNS
that/DT
occur/VBP
in/IN
the/DT
process/NN
of/IN
reoxygenation/NN
aside/NN
from/IN
hypoxia/NN
,/,
such/JJ
as/IN
the/DT
maturation/NN
of/IN
the/DT
newly/RB
formed/VBN
blood/NN
vessel/NN
and/CC
the/DT
formation/NN
of/IN
blood-brain/NN
barrier/RBR
./.
====================
Collectively/RB
,/,
in/IN
this/DT
study/NN
,/,
the/DT
cDNA/NN
microarray/NN
was/VBD
applied/VBN
to/TO
the/DT
screening/NN
of/IN
differential/JJ
gene/NN
expression/NN
patterns/NNS
in/IN
the/DT
astrocyte/NN
according/VBG
to/TO
oxygen/NN
tension/NN
./.
====================
We/PRP
suggests/VBZ
that/IN
further/RB
investigation/NN
of/IN
the/DT
gene/NN
expression/NN
data/NNS
from/IN
microarray/NN
experiments/NNS
can/MD
be/VB
extended/VBN
by/IN
building/VBG
interaction/NN
networks/NNS
using/VBG
previously/RB
characterized/VBN
information/NN
,/,
such/JJ
as/IN
the/DT
data/NNS
in/IN
AngioDB/NN
./.
====================
As/IN
accepted/VBN
,/,
the/DT
cDNA/NN
microarray/NN
is/VBZ
one/CD
of/IN
the/DT
best/JJS
methods/NNS
for/IN
screening/VBG
expression/NN
patterns/NNS
of/IN
thousands/NNS
of/IN
genes/NNS
in/IN
a/DT
single/JJ
experiment/JJ
and/CC
finding/NN
candidate/NN
genes/NNS
that/WDT
are/VBP
responsive/JJ
to/TO
a/DT
specific/JJ
condition/NN
among/IN
a/DT
number/NN
of/IN
genes/NNS
./.
====================
In/IN
the/DT
microarray/NN
analysis/NN
,/,
the/DT
method/NN
by/IN
which/WDT
the/DT
biological/JJ
significance/NN
of/IN
these/DT
genes/NNS
are/VBP
analyzed/VBN
and/CC
identified/VBD
is/VBZ
the/DT
most/JJS
important/JJ
./.
====================
We/PRP
have/VBP
illustrated/VBN
new/JJ
approaches/NNS
for/IN
prediction/NN
through/IN
the/DT
use/NN
of/IN
the/DT
interaction/NN
network/NN
and/CC
the/DT
preexisting/VBG
information/NN
that/IN
was/VBD
previously/RB
characterized/VBN
./.
====================
